Abstract Background and Aims: Hepatotoxic complications of long-term oral amiodarone
therapy have been well described; however, liver injury secondary to parenteral infusion of …

Amiodarone is a frequently prescribed anti-arrhythmic drug which is used to treat ventricular
and supraventricular tachyarrhythmia. Although it has excellent efficacy in controlling or …

Despite its efficacy in treating arrhythmias, the approved clinical use of amiodarone has
been limited to refractory ventricular and supraventricular arrhythmias. This is due to its high …

Although amiodarone is a widely used and effective long-term antiarrhythmic drug, it is
known to have life-threatening adverse effects, including acute hepatotoxicity. Although the …

Acute hepatotoxicity is a rare adverse effect of intravenous administration of amiodarone, but
may be fatal if not recognized early and treated in a timely manner. Herein we report two …

Amiodarone is a class III antiarrhythmic drug widely used for treating a number of cardiac
arrhythmias such as atrial fibrillation, both in young and elderly people. Its hepatotoxicity is …

We present the first description of amiodarone toxicity in the liver without phospholipidosis or
steatosis. In doing so, we will review the various effects of amiodarone toxicity in various …

Background Amiodarone is a class III antiarrhythmic drug which is widely used for the
treatment of both atrial and ventricular arrhythmias. Symptomatic liver injury with rapid …

Risk factors and underlying mechanisms for liver injury associated with amiodarone remain
elusive. This study aimed to investigate the drug-related covariates for acute liver injury by …

Amiodarone is an amphiphilic, iodinated, benzofuran derivative that is known to be effective
for refractory ventricular tachyarrhythmia. Amiodarone also is known to cause a variety of …